TNF-α and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3993-4000

  McHale, Julie F ^a   Harari, Olivier A ^a   Marshall, Diane ^a   Haskard, Dorian O ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; IMMUNOASSAY; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BRAIN; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNE SERA; INJECTIONS, INTRAPERITONEAL; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; KIDNEY; LUNG; LUPUS NEPHRITIS; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MYOCARDIUM; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033214841     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Isenberg, D. A., and A. C. Horsfall. 1998. Systemic lupus erythematosus. In Oxford Textbook of Rheumatology, 2nd Ed. P. J. Maddison, D. A. Isenberg, P. Woo, and D. N. Glass, eds. Oxford Medical Publications, Oxford, p. 1146.
2. Belmont, H. M., S. B. Abramson, and J. T. Lie. 1996. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 39:9.
3. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198.
4. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
5. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
6. Sunderrajan, E. V., W. N. McKenzie, T. R. Lieske, J. L. Kavanaugh, S. R. Braun, and S. E. Walker. 1986. Pulmonary inflammation in autoimmune MRL/Mp-lpr/ lpr mice: histopathology and bronchoalveolar lavage evaluation. Am. J. Pathol. 124:353.
7. Moyer, C. F., J. D. Strandberg, and C. L. Reinisch. 1987. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice: a histologic and immunocytochemical analysis. Am. J. Pathol. 127:229.
8. Vogelweid, C. M., G. C. Johnson, C. L. Besch-Williford, J. Basler, and S. E. Walker. 1991. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35:89.
9. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
10. Jones, D. A., L. V. McIntyre, C. W. Smith, and L. J. Picker. 1994. A two-step adhesion cascade for T cell/endothelial cell interactions under flow conditions. J. Clin. Invest. 94:2443.
11. Alon, R., P. D. Kassner, M. Woldemar Carr, E. B. Finger, M. E. Hemler, and T. A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243.
12. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427.
13. Wuthrich, R. P., A. M. Jevnikar, F. Takei, L. H. Glimcher, and V. E. Kelley. 1990. Intercellular adhesion molecule-1 (ICAM-1) expression is up-regulated in autoimmune murine lupus nephritis. Am. J. Pathol. 136:441.
14. Wuthrich, R. P. 1992. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 42:903.
15. Wang, W., S. Kobayashi, and T. Uede. 1992. Dysregulated expression of cellular adhesion molecules in autoimmune-prone mice. J. Dermatol. 19:831.
16. Hayashi, Y., N. Haneji, K. Yanagi, H. Higashiyama, H. Yagita, and H. Hamano. 1995. Prevention of adoptive transfer of murine Sjogren's syndrome into severe combined immunodencient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1). Clin. Exp. Immunol. 102:360.
17. Brey, R. L., A. A. Amato, K. Kagan-Hallet, C. B. Rhine, and C. L. Stallworth. 1997. Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice. Lupus Please verify journal title; it is not listed in our sources.6:645.
18. Lloyd, C. M., J.-A. Gonzalo, D. J. Salant, J. Just, and J.-C. Gutierrez-Ramos. 1997. Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J. Clin. Invest. 100:963.
19. Bullard, D. C., P. D. King, M. J. Hicks, B. Dupont, A. L. Beaudet, and K. B. Elkon. 1997. Intercellular adhesion molecule-1 deficiency protects mrl/ mpj-fas(lpr) mice from early lethality. J. Immunol. 159:2058.
20. Boswell, J. M., M. A. Yui, S. Endres, D. W. Burt, and V. E. Kelley. 1988. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J. Immunol. 141:118.
21. Boswell, J. M., M. A. Yui, D. W. Burt, and V. E. Kelley. 1988. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 141:3050.
22. Murray, L. J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:163.
23. Hamano, H., I. Saito, N. Haneji, Y. Mitsuhashi, N. Miyasaka, and Y. Hayashi. 1993. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice. Eur. J. Immunol. 23:2387.
24. Prud'homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-1 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32:495.
25. Tsai, C.-Y., T.-H. Wu, S.-F. Huang, K.-H. Sun, S.-C. Hsieh, S.-H. Han, H.-S. Yu, and C.-L. Yu. 1995. Abnormal splenic and thymic IL-4 and TNFα expression in MRL-lpr/lpr mice. Stand. J. Immunol. 41:157.
26. Yokoyama, H., B. Kreft, and V. R. Kelley. 1995. Biphasic increase in circulating and renal TNF-α in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 47:122.
27. Lemay, S., C. Mao, and A. K. Singh. 1996. Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney Int. 50:85.
28. Keelan, E. T. M., S. T. Licence, A. M. Peters, R. M. Binns, and D. O. Haskard. 1994. Characterization of E-selectin expression in vivo using a radiolabelled monoclonal antibody. Am. J. Physiol. 266:H279.
29. Harrison, A. A., C. J. Stocker, P. T. Chapman, Y. T. Tsang, T. Y. Huehns, R. H. Gundel, A. M. Peters, K. A. Davies, A. J. George, M. K. Robinson, and D. O. Haskard. 1997. Expression of VCAM-1 by vascular endothelial cells in immune-and non-immune inflammatory reactions in the skin. J. Immunol. 159: 4546.
30. Mulligan, M. S., A. A. Vaporciyan, M. Miyasaka, T. Tamatani, and P. A. Ward. 1993. Tumor necrosis factor or regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 142:1739.
31. Panes, J., M. A. Perry, D. C. Anderson, A. Manning, B. Leone, G. Cepinskas, C. L. Rosenbloom, M. Miyasaka, P. R. Kvietys, and D. N. Granger. 1995. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. J. Physiol. 38:H1955.
32. Eppihimer, M. J., B. A. Wolitzky, D. C. Anderson, M. A. Labow, and D. N. Granger. 1996. Heterogeneity of expression of E-and P-selectins in vivo. Circ. Res. 79:560.
33. Henninger, D. D., J. Panes, M. Eppihimer, J. Russell, M. Gerritsen, D. C. Anderson, and D. N. Granger. 1997. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs in the mouse. J. Immunol. 158:1825.
34. McHale, J., O. A. Harari, D. Marshall, and D. O. Haskard. 1999. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity response in mice: evidence for a dominant role of TNFα. J. Immunol. 162:1648.
35. Kelley, V. E., and J. B. Roths. 1985. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37:220.
36. Hahne, M., U. Jäger, S. Isenmann, R. Hallmann, and D. Vestweber. 1993. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J. Cell Biol. 121: 655.
37. McLean, I. W., and P. K. Nakane. 1974. Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22:1077.
38. Swerlick, R. A., K. H. Lee, L.-J. Li, N. T. Sepp, S. W. Caughman, and T. J. Lawley. 1992. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J. Immunol. 149:698.
39. Gille, J., R. A. Swerlick, T. J. Lawley, and S. W. Caughman. 1996. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor α and interleukin-1α in dermal microvascular endothelial cells. Blood 87:211.
40. Vissers, M. C., J. C. Fantone, R. Wiggins, and S. L. Kunkel. 1989. Glomerular basement membrane-containing immune complexes stimulate tumor necrosis factor and interleukin-1 production by human monocytes. Am. J. Pathol. 134:1.
41. Tedesco, F., M. Pausa, E. Nardon, M. Introna, A. Mantovani, and A. Dobrina. 1997. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 185:1619.
42. Simantov, R., J. M. LaSala, S. K. Lo, A. E. Gharavi, L. R. Sammaritano, J. E. Salmon, and R. L. Silverstein. 1995. Activation of cultured vascular endothelial cells by anti-phospholipid antibodies. J. Clin. Invest. 96:2211.
43. Lai, K. N., J. C. Leung, K. B. Lai, K. C. Wong, and C. K. Lai. 1996. Up-regulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 81:229.
44. Mizgerd, J. P., B. B. Meek, G. J. Kutkoski, D. C. Bullard, A. L. Beaudet, and C. M. Doerschuk. 1996. Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J. Exp. Med. 184:639.
45. Belmont, H. M., J. Buyon, R. Giorno, and S. Abramson. 1994. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum. 37:376.
46. Pallis, M., D. K. Robson, D. O. Haskard, and R. J. Powell. 1993. Distribution of cell adhesion molecules in peripheral muscle from patients with SLE. Ann. Rheum. Dis. 52:667.
47. Yokoyama, H., M. Takaeda, T. Wada, S. Ohta, Y. Hisada, C. Segawa, K. Furuichi, and K. Kobayashi. 1997. Glomerular ICAM-1 expression related to circulating TNF-α in human glomerulonephritis. Nephron 76:425.
48. Wellicome, S., P. Kapahi, J. C. Mason, Y. Lebranchu, H. Yarwood, and D. O. Haskard. 1993. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol. 92:412.
49. Kling, E., S. Bieg, M. Boehme, and W. A. Scherbaum. 1993. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus. Clin. Invest. 71:299.
50. Maury, C. P. J., and A.-M. Teppo. 1989. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 32:146.
51. Studnicka-Benke, A., G. Steiner, P. Petera, and J. S. Smolen. 1996. Tumor necrosis factor α and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br. J. Rheumatol. 35:1067.
52. Gabay, C., N. Cakir, F. Moral, P. Roux-Lombard, O. Meyer, J. M. Dayer, T. Vischer, H. Yazici, and P. A. Guerne. 1997. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J. Rheumatol. 24:303.
53. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, and J. V. O'Connor. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163:1433.
54. Libby, P., J. M. Ordovas, K. R. Auger, A. H. Robbins, L. K. Birinyi, and C. A. Dinarello. 1986. Endotoxin and tumor necrosis factor induce interleukin 1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124: 179.
55. Brennan, F. M., A. Jackson, D. Chantry, R. Maini, and M. Feldman. 1989. Inhibitory effect of TNFα antibodies on the synovial cell interleukin-1 production in rheumatoid arthritis. Lancet i:244.
56. Jacob, C. O., and H. O. McDevitt. 1988. Tumor necrosis factor-α in murine autoimmune "lupus" nephritis. Nature 331:356.
57. 1 mice. Clin. Immunol. Immunopathol. 52:421.
58. Brennan, D. C., M. A. Yui, R. P. Wuthrich, and V. E. Kelley. 1989. Tumor necrosis factor and IL-1 in New Zealand Black/White mice: enhanced gene expression and acceleration of renal injury. J. Immunol. 143:3470.
59. Zhou, T., C. K. Edwards, P. Yang, Z. Wang, H. Bluethmann, and J. D. Mountz. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 156:2661.
60. Feldmann, M., M. J. Elliott, J. N. Woody, and R. N. Maini. 1997. Anti-tumor necrosis factor-α therapy of rheumatoid arthritis. Adv. Immunol. 64:283.
61. Targan, S. R., S. B. Hanauer, S. J. van Deventer, L. Mayer, D. H. Present, T. Braakman, K. L. De Woody, T. F. Schaible, and P. J. Rutgeerts. 1997. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N. Engl. J. Med. 337:1029.
62. Stack, W. A., S. D. Mann, A. J. Roy, P. Heath, M. Sopwith, J. Freeman, G. Holmes, R. Long, A. Forbes, and M. A. Kamm. 1997. Randomized controlled trial of CDP571 antibody to tumor necrosis factor α in Crohn's disease. Lancet 349:521.